Clinical Focus ›› 2026, Vol. 41 ›› Issue (1): 91-95.doi: 10.3969/j.issn.1004-583X.2026.01.016
• Original article • Previous Articles
Received:2025-08-25
Online:2026-01-20
Published:2026-02-02
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.lchc.cn/EN/10.3969/j.issn.1004-583X.2026.01.016
| [1] | Löscher W, Potschka H, Sisodiya SM, et al. Drug resistance in epilepsy: Clinical impact, potential mechanisms, and new innovative treatment options[J]. Pharmacol Rev, 2020, 72(3):606-638. doi:10.1124/pr.120.019539. |
| [2] | Lin TK, Chen SD, Lin KJ, et al. Seizure-induced oxidative stress in status epilepticus: Is antioxidant beneficial?[J]. Antioxidants (Basel), 2020, 9(11):1029.doi:10.3390/antiox9111029. |
| [3] | Lattanzi S, Striano P. The impact of perampanel and targeting AMPA transmission on anti-seizure drug discovery[J]. Expert Opin Drug Discov, 2019, 14(3):195-197. doi:10.1080/17460441.2019.1566318. |
| [4] | Dixon SJ, Lemberg KM, Lamprecht MR, et al. Ferroptosis: An iron-dependent form of nonapoptotic cell death[J]. Cell, 2012, 149(5):1060-1072. doi:10.1016/j.cell.2012.03.042. |
| [5] | Chen S, Chen Y, Zhang Y, et al. Iron metabolism and ferroptosis in epilepsy[J]. Front Neurosci, 2020, 14:601193. doi:10.3389/fnins.2020.601193. |
| [6] | Cai Y, Yang Z. Ferroptosis and its role in epilepsy[J]. Front Cell Neurosci, 2021, 15:696889. doi:10.3389/fncel.2021.696889. |
| [7] | Shay JW, Homma N, Zhou R, et al. Abstracts from the 3rd International Genomic Medicine Conference (3rd IGMC 2015): Jeddah, Kingdom of Saudi Arabia. 30 November - 3 December 2015[J]. BMC Genomics, 2016, 17 Suppl 6(Suppl 6): 487. doi:10.1186/s12864-016-2858-0. |
| [8] | Gao M, Monian P, Quadri N, et al. Glutaminolysis and transferrin regulate ferroptosis[J]. Mol Cell, 2015, 59(2):298-308. doi:10.1016/j.molcel.2015.06.011. |
| [9] | Stockwell BR, Friedmann Angeli JP, Bayir H, et al. Ferroptosis: A regulated cell death nexus linking metabolism, redox biology, and disease[J]. Cell, 2017, 171(2):273-285. doi:10.1016/j.cell.2017.09.021. |
| [10] | Jinyun Liu, Xiaojun Xia, Peng Huang. xCT: A critical molecule that links cancer metabolism to redox signaling[J]. Mol Ther, 2020, 28(11):2358-2366. doi: 10.1016/j.ymthe.2020.08.021.Epub 2020 Sep 2. |
| [11] | Yao MY, Liu T, Zhang L, et al. Role of ferroptosis in neurological diseases[J]. Neurosci Lett, 2021, 747:135614. doi:10.1016/j.neulet.2020.135614. |
| [12] | Yuan GM, Su FY, Li PY, et al. Cerebral protective effect of acupuncture based on its regulative effect on programmed cell death[J]. Zhen Ci Yan Jiu, 2025, 50(2):210-216. doi:10.13702/j.1000-0607.20230934. |
| [13] | Balgoma D, Kullenberg F, Calitz C, et al. Anthracyclins increase PUFAs: Potential implications in ER stress and cell death[J]. Cells, 2021, 10(5):1163.doi:10.3390/cells10051163. |
| [14] | 魏颍, 王丽霞, 阴俊俊, 等. 基于Nrf2/SLC7A11/GPX4信号通路探讨失笑散对脑缺血再灌注损伤大鼠神经功能及铁死亡的影响[J/OL]. 中国实验方剂学杂志, 1-13[2025-11-28].https://doi.org/10.13422/j.cnki.syfjx.20252405. |
| [15] | Mortensen MS, Ruiz J, Watts JL. Polyunsaturated fatty acids drive lipid peroxidation during ferroptosis[J]. Cells, 2023, 12(5):804. doi:10.3390/cells12050804. |
| [16] | Ding K, Liu C, Li L, et al. Acyl-CoA synthase ACSL4: An essential target in ferroptosis and fatty acid metabolism[J]. Chin Med J (Engl), 2023, 136(21):2521-2537.doi:10.1097/CM9.0000000000002533. |
| [17] | Mohan M, Mannan A, Kakkar C, et al. Nrf2 and ferroptosis: Exploring translational avenues for therapeutic approaches to neurological diseases[J]. Curr Drug Targets, 2025, 26(1):33-58. doi:10.2174/0113894501320839240918110656. |
| [18] | Mahawar S, Rakshit D, Patel I, et al. Fisetin-loaded chitosan nanoparticles ameliorate pilocarpine-induced temporal lobe epilepsy and associated neurobehavioral alterations in mice: Role of ROS/TNF-α-NLRP3 inflammasomes pathway[I]. Nanomedicine, 2024, 59:102752. doi:10.1016/j.nano.2024.102752. |
| [19] | Park VS, Pope LE, Ingram J, et al. Lipid composition differentiates ferroptosis sensitivity between in vitro and in vivo systems[J]. bioRxiv [Preprint], 2024, 2024.11.14.622381.doi: 10.1101/2024.11.14.622381. |
| [20] | Liu X, Zhuang L, Gan B. Disulfidptosis: Disulfide stress-induced cell death[J]. Trends Cell Biol, 2024, 34(4):327-337. doi:10.1016/j.tcb.2023.07.009. |
| [21] | Seibt T, Wahida A, Hoeft K, et al. The biology of ferroptosis in kidney disease[J]. Nephrol Dial Transplant, 2024, 39(11):1754-1761. doi:10.1093/ndt/gfae097. |
| [22] | Xue Q, Yan D, Chen X, et al. Copper-dependent autophagic degradation of GPX4 drives ferroptosis[J]. Autophagy, 2023, 19(7):1982-1996. doi:10.1080/15548627.2023.2165323. |
| [23] | Wang L, Liu Y, Du T, et al. ATF3 promotes erastin-induced ferroptosis by suppressing system Xc[J]. Cell Death Differ, 2020, 27(2):662-675. doi:10.1038/s41418-019-0380-z. |
| [24] | Rochette L, Dogon G, Rigal E, et al. Lipid peroxidation and iron metabolism: Two corner stones in the homeostasis control of ferroptosis[J]. Int J Mol Sci, 2022, 24(1):449. doi:10.3390/ijms24010449. |
| [25] | Liang P, Zhang X, Zhang Y, et al. Neurotoxic A1 astrocytes promote neuronal ferroptosis via CXCL10/CXCR3 axis in epilepsy[J]. Free Radic Biol Med, 2023, 195:329-342. doi:10.1016/j.freeradbiomed.2023.01.002. |
| [26] | Wang Y, Zhao Y, Wang H, et al. Histone demethylase KDM3B protects against ferroptosis by upregulating SLC7A11[J]. FEBS Open Bio, 2020, 10(4):637-643. doi:10.1002/2211-5463.12823. |
| [27] | Cui P, Liu W, Zhao Y, et al. The association between H3K4me3 and antisense transcription[J]. Genomics Proteomics Bioinformatics, 2012, 10(2):74-81. doi:10.1016/j.gpb.2012.05.001. |
| [28] | Li S, Wang Y, Wang W, et al. The national comprehensive governance for epilepsy prevention and control in China[J]. Epilepsia Open, 2022, 7(1):27-35. doi:10.1002/epi4.12554. |
| [29] | Ralhan I, Chang J, Moulton MJ, et al. Autolysosomal exocytosis of lipids protect neurons from ferroptosis[J]. J Cell Biol, 2023, 222(6):e202207130. doi:10.1083/jcb.202207130. |
| [30] | Chen KN, Guan QW, Yin XX, et al. Ferrostatin-1 obviates seizures and associated cognitive deficits in ferric chloride-induced posttraumatic epilepsy via suppressing ferroptosis[J]. Free Radic Biol Med, 2022, 179:109-118. doi:10.1016/j.freeradbiomed.2021.12.268. |
| [31] | Mao XY, Zhou HH, Jin WL. Ferroptosis induction in pentylenetetrazole kindling and pilocarpine-induced epileptic seizures in mice[J]. Front Neurosci, 2019, 13:721. doi:10.3389/fnins.2019.00721. |
| [32] | Jia JN, Yin XX, Li Q, et al. Neuroprotective effects of the anti-cancer drug lapatinib against epileptic seizures via suppressing glutathione peroxidase 4-dependent ferroptosis[J]. Front Pharmacol, 2020, 11:601572.doi: 10.3389/fphar.2020.601572. |
| [33] | Rusina E, Bernard C, Williamson A. The kainic acid models of temporal lobe epilepsy[J]. eNeuro, 2021, 8(2): ENEURO.0337-20.2021. doi: 10.1523/ENEURO.0337-20.2021. |
| [34] | 刘大通, 孙梅玲, 赵涛. 程序性细胞死亡在子痫前期中的作用[J/OL]. 生命的化学, 1-9[2025-12-09].https://doi.org/10.13488/j.smhx.20250208. |
| [1] | Lin Bincheng, Lin Gangxi. Effects of etiology and preoperative course of disease on the efficacy of drug-resistant epilepsy in children [J]. Clinical Focus, 2025, 40(6): 527-531. |
| [2] | Wang Xiaoxiao, Hu Yanfeng, Qi Xiufeng, Zhao Junjie. Acute pulmonary embolism with epilepsy attack as the first clinical manifestation: A case report and literature review [J]. Clinical Focus, 2025, 40(6): 532-536. |
| [3] | Wang Caizhen, Miao Lina, Chen Yuan, Li Shuangcheng. Effectiveness of high-frequency vagus nerve stimulation in the treatment of drug-resistant epilepsy: A meta-analysis [J]. Clinical Focus, 2024, 39(7): 593-597. |
| [4] | Ding Siqi, Liu Shihua, Zhang Chao, Zhong Ping, Cao Li. Risk factors for epilepsy after delayed post-stroke epilepsy and its clinical correlation with blood Hcy, hs-CRP and D-D [J]. Clinical Focus, 2023, 38(10): 893-897. |
| [5] | Zhao Shuzhen, Wang Sanping, Zhao Xiaoyun. SLC32A1 gene mutation in hereditary epilepsy with febrile convulsion addition: A case report and literature review [J]. Clinical Focus, 2023, 38(5): 451-454. |
| [6] | . [J]. Clinical Focus, 2014, 29(8): 942-943. |
| [7] | . [J]. CLINICAL FOCUS, 2013, 28(11): 1315-1318. |
| [8] | MU Hong-di;LIU Shi-ling;GENG Li-juan. Effect of laser oxygen liquid extract on expression of nestin of hippocampal tissues for status epilepticus rats [J]. Clinical Focus, 2013, 28(5): 525-0. |
| [9] | . [J]. CLINICAL FOCUS, 2013, 28(3): 308-309. |
| [10] | . [J]. Clinical Focus, 2013, 28(2): 220-0. |
| [11] | . [J]. Clinical Focus, 2013, 28(2): 224-226. |
| [12] | . [J]. Clinical Focus, 2012, 27(21): 1930-1933. |
| [13] | . [J]. Clinical Focus, 2012, 27(15): 1333-1334. |
| [14] | LIANG Ying-kui;ZHAO Wen-rui;CHUAN Ling;GUO Feng;LEI Xiao;WANG Sheng;HOU Xiao-ming. Value of 18F-FDG PET/CT in localization of epileptogenic focus and therapeutic decision for epilepsy [J]. Clinical Focus, 2012, 27(14): 1201-1204. |
| [15] | LI Cheng-yao;CHEN Ying;CHEN Hong;YANG Hong;LIU Zhang. Correlation study on intellectual level and structure of children with epilepsy and clinical characteristics [J]. Clinical Focus, 2012, 27(12): 1039-1042. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||